Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-05

FDA Approved: FERRIC CITRATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Ferric Citrate from Mylan as an original application to treat hyperphosphatemia in adults with chronic kidney disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric citrate (ferric citrate)

Snippet

ORIG AP for FERRIC CITRATE (FERRIC CITRATE)